Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk
Piramal is among global drugmakers increasingly seeking to reduce their reliance on China for pharmaceutical ingredients and manufacturing, amid rising geopolitical tensions
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.